Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q200

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
385,250
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137774-24-000284
Form type
SC 13G/A
Filer
MARINUS PHARMACEUTICALS, INC.
CIK
CIK 1267813
Filed
Nov 14, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub